share_log

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

HC Wainwright & Co.以买入评级启动对OKYO Pharma的报道,宣布目标股价为4美元
Benzinga ·  2023/11/02 07:07

HC Wainwright & Co. analyst Yi Chen initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Price Target of $4.

HC Wainwright & Co. 分析师陈毅以买入评级开始对OKYO Pharma(纳斯达克股票代码:OKYO)进行报道,并宣布目标股价为4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发